Skip to content

Clinical trials

Observational Disease Progression trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Observational Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20113
20161
20192
20201
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Brompton & Harefield NHS Foundation Trust2
Biogen1
Eli Lilly and Company1
Heidelberg University1
Keele University1
Novartis Pharmaceuticals1
Royal Devon and Exeter NHS Foundation Trust1
University of Cambridge1
University of Nottingham1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression11
Bronchitis, Chronic2
Cardiovascular Diseases2
Diabetes Mellitus, Type 12
Lung Diseases2
Lung Diseases, Obstructive2
Pulmonary Disease, Chronic Obstructive2
Pulmonary Emphysema2
Vascular Diseases2
Breast Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.